{"docid":"VWS-WOO-Spc-905299","collapsed":true,"count":1,"unchecked":0,"snapshots_total":1,"versions":[{"archive_id":"14507","bestandsnaam":"VWS-WOO-Spc-905299-Final_EU_Briefing_for_Premier_Rutte_on_COVID19-31032020.docx.pdf","created_date":"2025-02-18 12:18:00","last_seen":"2025-02-18 12:18:00","from_file":"Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","snippet":"905299\nBriefingforPremier Rutte onSARS-CoV-2 vaccine\nEUcooperation\n30/03/2020\nContext:\neo Based onthekey attributes ofJanssen’s technology platforms and our established Vaccines\ndevelopmental and manu","digest":"51f9a590e93c","dupes":1,"date_to":"2025-02-18 12:18:00","date_from":"2025-02-18 12:18:00","unchecked":false}],"raw":[{"archive_id":"14507","bestandsnaam":"VWS-WOO-Spc-905299-Final_EU_Briefing_for_Premier_Rutte_on_COVID19-31032020.docx.pdf","created_date":"2025-02-18 12:18:00","last_seen":"2025-02-18 12:18:00","from_file":"Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","snippet":"905299\nBriefingforPremier Rutte onSARS-CoV-2 vaccine\nEUcooperation\n30/03/2020\nContext:\neo Based onthekey attributes ofJanssen’s technology platforms and our established Vaccines\ndevelopmental and manu","digest":"51f9a590e93c"}],"filename":"Final EU Briefing for Premier Rutte on COVID19-31032020.docx","truncated":false,"elapsed_ms":13}